Cabot’s (CBT) “Buy” Rating Reiterated at UBS Group

UBS Group reiterated their buy rating on shares of Cabot (NYSE:CBT) in a report issued on Thursday, Marketbeat reports.

Several other research analysts have also recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Mizuho upped their target price on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $81.00 price target on shares of Cabot in a report on Thursday. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Finally, JPMorgan Chase & Co. reduced their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $74.00.

Cabot Stock Up 1.4%

Shares of NYSE CBT opened at $72.80 on Thursday. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50. The company has a market cap of $3.85 billion, a P/E ratio of 12.11, a P/E/G ratio of 3.81 and a beta of 0.89. Cabot has a 52 week low of $58.33 and a 52 week high of $92.89. The business has a 50-day simple moving average of $64.88 and a two-hundred day simple moving average of $72.26.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a return on equity of 24.55% and a net margin of 8.91%.The firm had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same period in the previous year, the company posted $1.80 earnings per share. The company’s quarterly revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts anticipate that Cabot will post 7.57 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were given a $0.45 dividend. The ex-dividend date was Friday, November 28th. This represents a $1.80 annualized dividend and a yield of 2.5%. Cabot’s payout ratio is presently 29.95%.

Hedge Funds Weigh In On Cabot

A number of hedge funds have recently modified their holdings of CBT. Gabelli Funds LLC raised its position in Cabot by 1.3% during the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock valued at $1,032,000 after purchasing an additional 180 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of Cabot by 1.7% during the second quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company’s stock valued at $791,000 after acquiring an additional 181 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 189 shares during the period. Ferguson Wellman Capital Management Inc. boosted its holdings in Cabot by 4.2% in the second quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock valued at $375,000 after acquiring an additional 200 shares in the last quarter. Finally, First Citizens Bank & Trust Co. increased its position in Cabot by 1.4% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock valued at $1,107,000 after purchasing an additional 206 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.